{
    "nctId": "NCT00869466",
    "briefTitle": "Weight Control Programs in Women Who Have Undergone Surgery for Early Stage Breast Cancer",
    "officialTitle": "B- AHEAD Study (Breast - Activity & Healthy Eating After Diagnosis) Randomised Comparison of 3 Weight Control Programmes During Adjuvant Treatment for Early Breast Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Weight Changes",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 409,
    "primaryOutcomeMeasure": "Changes in body weight and composition (i.e., body fat, fat-free mass, dual energy x-ray absorptiometry, bioelectrical impedance, and waist and hip circumference) at baseline and at 6 and 12 months",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of early breast cancer\n\n  * Stage I-III disease\n  * Invasive or in situ disease\n* No metastatic or inoperable disease\n* Underwent primary surgery for primary breast cancer at UHSM, North Manchester, Royal Oldham, Stepping Hill, Hope Macclesfield General, Tameside General, Leighton Hospitals, or Rochdale Infirmary within the past 10 weeks\n* Receiving/due to start adjuvant chemotherapy, radiotherapy, endocrine therapy, or no adjuvant treatment\n* Hormonal receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Pre or postmenopausal status\n* Any weight allowed\n* Resident within Greater Manchester or Cheshire area\n* No physical/psychiatric condition that impairs compliance or mobility as assessed from medical history or baseline fitness assessment, including any of the following:\n\n  * Insulin-requiring diabetes (non-insulin requiring diabetics are eligible)\n  * Serious digestive and/or absorptive problems, including inflammatory bowel disease\n  * Cardiovascular or respiratory disease\n  * Musculoskeletal disease or joint problems\n  * Psychiatric disorders or conditions (e.g., untreated major depression, psychosis, substance abuse, or severe personality disorder)\n* Not considering reconstructive surgery in the next 12 months\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No concurrent daily medication known to affect body composition (e.g., corticosteroids)\n\n  * Patients receiving 2-3 days of steroids with chemotherapy are eligible\n* No prior neoadjuvant chemotherapy or endocrine therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}